However, in breast cancer patients, low CRIP1 expression could enhance cell proliferation and invasion by enhancing the mitogen-activated protein kinase phosphorylation and reducing the CDC2 phosphorylation (Ludyga et al., 2013). The gene discussed is WNK2; the disease is breast carcinoma.